Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02180074 · ClinicalTrials.gov registry record

Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease

A clinical trial, sponsored by Louisiana State University Health Sciences Center Shreveport.

Completed
Registry status
137
Enrollment target

NCT02180074 is a clinical trial that has completed, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 137 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02180074 has completed, sponsored by Louisiana State University Health Sciences Center Shreveport.

COMPLETED
Registry status
137 participants
Enrollment target

Study Summary

Cardiovascular disease which includes coronary artery disease and peripheral artery disease remains the leading cause of death among women in the United States. The impact of cardiovascular in women was not recognized by clinicians for a long time. It is now evident that, women suffer the consequences of cardiovascular at rates at least as high as those observed in men but there are still major gaps in our understanding this disease in women. Hydrogen sulfide (H2S), a gaseous mediator plays an important role in the cardiovascular system. Research has demonstrated it's critical role in animal ischemia reperfusion models. Hydrogen sulfide exists in distinct biological pools in blood. Recently, the Kevil lab has pioneered the development of new analytical techniques for accurate measurement of all biological pools of H2S. By measuring these distinct pools of H2S in women with and without cardiovascular disease the investigators hope to further understanding of role of H2S in pathophysiology of cardiovascular disease. This research will help to assess the ability of H2S and its distinct biological pools to potentially be a diagnostic marker or a therapeutic target for cardiovascular disease.

Trial Details

FieldValue
Enrollment Target 137 participants
Start Date 2013-09
Est. Completion 2017-05-07

What the Registry Record Tells You About NCT02180074

The ClinicalTrials.gov registry entry for NCT02180074 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02180074 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02180074 about?

NCT02180074 is a clinical study titled "Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease". Cardiovascular disease which includes coronary artery disease and peripheral artery disease remains the leading cause of death among women in the United States. The impact of cardiovascular in women was not recognized by clinicians for a long time. It is now evident that, women suffer the consequenc...

What is the current status of trial NCT02180074?

This trial is currently completed. The enrollment target is 137 participants. The study started on 2013-09. Estimated completion is 2017-05-07.

Who is sponsoring clinical trial NCT02180074?

This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.